MAPK8 and ischemia: In the type II diabetic and ischemia/reperfusion liver injury models, Rg1 significantly improving inflammatory response factors, oxidation indices, and lipid levels, while exhibiting anti-apoptotic effects and inhibit the activation of c-Jun N-terminal kinase (JNK) signaling pathway (Zhang et al., 2015; Tian et al., 2017).